Cardiovascular Diseases Research federal funding in Utah

NIH CFDA 93.837 joined to Utah

CFDA 93.837 is titled Cardiovascular Diseases Research. Filtered to Utah place of performance, obligations sum to $190,160,080.71 on 138 awards. The national CFDA 93.837 hub includes every state. Utah federal spending includes every program. This tie is the overlap — the pair, not a causal story. Cardiovascular diseases research typically posts as investigator-initiated and center grants. Award count is not a patient count.

One hundred thirty-eight awards sit beside the dollar total. Modifications can sit next to base awards; unique recipients are unpublished. Readers sometimes treat a large CFDA–state total as if it were a budget line the state legislature passed. $190,160,080.71 is not that. It is the USAspending obligation sum on awards tagged 93.837 and UT. Correlation is not causation. Campaign-finance tables are a different dataset; donations do not fund these awards.

Heart-disease research is not GI Bill or BRIC

Biomedical research training (93.859) and other NIH institute catalogs are different CFDA numbers. Those grants do not sit inside 93.837. Packet facts are Utah, CFDA 93.837, $190,160,080.71, and 138 awards. Formula shares, recipient lists, and outcome scores are not in the facts. The catalog title names Cardiovascular Diseases Research, not hospital claims or a mortality ranking.

The only numeric facts on this packet are $190,160,080.71, 138 awards, CFDA 93.837, program title Cardiovascular Diseases Research, and geography UT/Utah. Any other dollar, year, recipient, or percentage would be invented. Trivial arithmetic is allowed: 138 awards into $190,160,080.71 is about $1.38 million per award. That quotient is a mean of records, not a typical household, student, patient, or cardiovascular research unit.

Utah as a research geography tag

Utah’s place-of-performance tag can cover a statewide award even when activity sits along the Wasatch Front. Salt Lake City and Provo are not columns. Awards coded to Idaho, Nevada, Colorado, or Arizona stay out. Place of performance UT is a two-letter code in the award file. It does not prove where every subcontract ran, and it does not convert $190,160,080.71 into a county map. Awards with a different state code are outside this cell even if people, patients, or riders cross the border.

Utah federal spending is the all-program parent. CFDA 93.837 is the national program page without the Utah filter. Utah programs lists other catalogs beside Cardiovascular Diseases Research. $190,160,080.71 is not Utah’s complete federal footprint.

One hundred thirty-eight awards and the mean

$190,160,080.71 ÷ 138 is about $1.38 million per award. That average is a ratio of two packet facts, not a median and not a posted unit price. With n = 138, a few large instruments can dominate, or many small actions can stack. Treat one hundred thirty-eight as a record count in an aggregate, not as one hundred thirty-eight finished projects. USAspending obligations can be positive new awards or net of downward modifications; $190,160,080.71 is the net total supplied in the facts.

Without a transaction register on this page, you cannot see how many of the 138 rows are continuations, renewals, or corrections. Unique recipients are unpublished. Utah GI Bill, Unemployment Insurance, and BRIC cells in this harvest use VA, DOL, and FEMA catalogs. Keep NHLBI-style research on 93.837.

Death-rate rankings the cell cannot produce

An obligation is a legal commitment. An outlay is a payment. $190,160,080.71 is the former. This packet has no outlay total, no fiscal-year split, and no de-obligation history. Citing the figure as cash already cleared in Utah over-reads the field. Keep the obligation word when you quote Cardiovascular Diseases Research in Utah. FEC filings do not pay USAspending cells. The join cannot say that Utah specialized in cardiovascular research because of federal demand, or the reverse.

Parents of the Utah × 93.837 overlay

The overlay target is Cardiovascular Diseases Research in Utah. Open that path for the same $190,160,080.71 / 138-award cell in the site’s data chrome. CFDA 93.837 drops the Utah filter. Utah federal spending drops the CFDA filter. Utah programs lists sibling catalogs. All spending ties is the directory of other pairs. None of those links convert the cell into hospital claims or a mortality ranking, into outlays this packet omits, or into a causal claim. Cite both sides: Cardiovascular Diseases Research and Utah, $190,160,080.71, 138 awards, USAspending.gov, obligations only.

Questions

How much cardiovascular-diseases research is obligated in Utah?

USAspending.gov records $190,160,080.71 in Cardiovascular Diseases Research obligations (CFDA 93.837) with Utah place of performance across 138 awards. That is an obligation aggregate for the program–state pair, not an outlay and not Utah’s full federal book. Original filings remain on USAspending.gov.

Does 138 awards mean 138 patients?

The extract lists 138 award actions totaling $190,160,080.71. One hundred thirty-eight awards sit beside the dollar total. Modifications can sit next to base awards; unique recipients are unpublished. Average obligation per award is about $1.38 million, a ratio of two packet facts, not a typical invoice. Unique recipients are not published on this packet.

Is this Utah’s full NIH spending?

No. $190,160,080.71 is only the Cardiovascular Diseases Research cell tagged to Utah. Other CFDA programs with Utah place of performance sit on Utah federal spending. Nationwide CFDA 93.837 is not limited to Utah. Mixing sibling catalogs into this total would overstate the join.

Where is the live 93.837-in-Utah table?

Cardiovascular Diseases Research in Utah is the live table for this pair. CFDA 93.837 is the national program hub. Utah federal spending is the statewide parent. Utah programs indexes other catalogs. All spending ties lists other pairs. Prefer those tables after later USAspending ingests; this page quotes only 93.837 × UT at $190,160,080.71.